Global Molecular Imaging Market is valued approximately USD 4.77 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 7.9% over the forecast period 2021-2027. Molecular imaging is in demand as it gives the detailed picture of functions in the body at molecular level which is used to diagnose several diseases. Rise in healthcare expenditure and emergence of artificial intelligence in radiology are the driving factors for the adoption of Molecular Imaging across the forecast period. Adoption and advancements in technologies such as PET/CT, MRI, robotics, non-ionizing imaging techniques, and Nano-biotechnology has helped to market to grow. Molecular imaging devices produces minimal ionizing radiations and thus, eliminating the chances of risk. According to World Health Organization (WHO), per capita healthcare expenditure was USD 351 in 2000 has grown to USD 926 by 2018. However, requirement of digitization and higher cost of investment restraints the growth of the market over the forecast period of 2020-2027. Also, increase in functionality of products and rapid pace of innovation is likely to boost the market growth during the forecast period.

The geographical study of the global Fishing Reels market includes Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is dominating the market across the world in terms of market share by projecting fastest growth, having advancement of technology and high awareness among patient population. Whereas, Asia-Pacific is considered to be the fasted growing market over the forecast period 2020-2027. Factors such as rising disorder, increasing government support for healthcare R&D, and rising investment in the healthcare sector would drive the market for the Molecular Imaging across Asia-Pacific region.

Major market player included in this report are:
GE Healthcare
Koninklijke Philips N.V
Siemens Healthcare Pvt Ltd.
Shimadzu Corporation
Hitachi High-Technology Corporation
Esaote Spa
Bruker
Canon Medical Systems Corporation
Fujifilm Holdings Corporation
Carestream Health

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Technology:
Gamma Camera
Single Photon Emission Computed Technology
Positron Emission Tomography
Magnetic Resonance Spectroscopy
Optical Imaging
Molecular Ultrasound Imaging
By Application:
Cancer
Heart Disease
Brain Disorder
Gastrointestinal Disorder
Lung Disorder
Bone Disorder
Others
By End User:
Hospitals
Diagnostic Centres
Others




By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027

Target Audience of the Global Molecular Imaging Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors